FEETEG and LAL-D Patient Oganization – Together for Research

5 Sep, 2026 | blog

Firma acuerdo FEETEG & LALDPO

FEETEG and LAL-D Patient Organization Renew Their Collaboration Agreement

On September 3, 2026, the Spanish Foundation for the Study and Treatment of Gaucher Disease and other Lysosomal Disorders (FEETEG) and LAL-D Patient Organization officially renewed their collaboration agreement, reinforcing a long-standing partnership dedicated to advancing research, education, scientific dissemination, and patient support in the field of lysosomal diseases.

 

Firma acuerdo FEETEG & LALDPO

 

Through this renewed agreement, both organizations will continue working together to promote research initiatives related to Lysosomal Acid Lipase Deficiency (LAL-D) and other lysosomal disorders, foster collaboration among researchers, healthcare professionals, patients, and families, and support new opportunities for scientific exchange and education.

 

The agreement also strengthens the collaboration surrounding en-LISOS, the Spanish-language scientific journal focused on lysosomal diseases, as well as the development of its new digital platform.
By combining the scientific expertise of FEETEG with the patient-centered perspective of LAL-D Patient Organization, both entities aim to contribute to better diagnosis, improved care, increased awareness, and greater opportunities for people living with rare diseases.
Together, FEETEG and LAL-D Patient Organization remain committed to ensuring that scientific knowledge about lysosomal diseases is accessible, independent, and useful for those who research, treat, and live with these conditions.

Because advancing knowledge today means improving lives tomorrow.